IGMSX
Price
$9.49
Change
+$0.02 (+0.21%)
Updated
Sep 20 closing price
RNPFX
Price
$64.96
Change
-$0.39 (-0.60%)
Updated
Sep 20 closing price
Ad is loading...

IGMSX vs RNPFX

Header iconIGMSX vs RNPFX Comparison
Open Charts IGMSX vs RNPFXBanner chart's image
Voya Global Insights Portfolio S
Price$9.49
Change+$0.02 (+0.21%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R5
Price$64.96
Change-$0.39 (-0.60%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IGMSX vs RNPFX Comparison Chart
Loading...
VS
IGMSX vs. RNPFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMSX is a StrongBuy and RNPFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RNPFX has more cash in the bank: 145B vs. IGMSX (1.13B). RNPFX pays higher dividends than IGMSX: RNPFX (1.07) vs IGMSX (0.00). IGMSX was incepted earlier than RNPFX: IGMSX (22 years) vs RNPFX (22 years). IGMSX is a more actively managed with annual turnover of: 107.00 vs. RNPFX (17.00). IGMSX has a lower initial minimum investment than RNPFX: IGMSX (0) vs RNPFX (250). RNPFX annual gain was more profitable for investors over the last year : 23.22 vs. IGMSX (-36.01). RNPFX return over 5 years is better than : 46.86 vs. IGMSX (-42.90).
IGMSXRNPFXIGMSX / RNPFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years22 years-
Gain YTD-43.22516.332-265%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B145B1%
Annual Yield % from dividends0.001.07-
Returns for 1 year-36.0123.22-155%
Returns for 3 years-62.26-3.521,770%
Returns for 5 years-42.9046.86-92%
Returns for 10 years-45.7773.19-63%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSS18.680.06
+0.32%
Kohls Corp
TIMB16.95-0.05
-0.29%
TIM SA
YORW37.90-1.09
-2.80%
York Water Company
INM0.26-0.01
-3.00%
InMed Pharmaceuticals
HOWL2.19-0.21
-8.75%
Werewolf Therapeutics